12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks showed significant movement. Tivic Health Systems (TIVC) saw a 116.8% increase, while SenesTech (SNES) rose by 65.78%. ZyVersa Therapeutics (ZVSA) and Cingulate (CING) also experienced gains. On the downside, TC BioPharm (TCBP) dropped by 89.2%, Aclaris Therapeutics (ACRS) fell by 85.6%, and Verve Therapeutics (VERV) declined by 31.53%. Other stocks such as TRACON Pharma (TCON), Monopar Therapeutics (MNPR), and Singular Genomics Systems (OMIC) also saw decreases. Earnings reports seem to be a driving factor for many of these movements.
November 13, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
SenesTech stock increased by 65.78% to $0.4 following its Q3 earnings report released 2 days ago.
The recent Q3 earnings report is likely the catalyst for the sharp increase in SNES's stock price, suggesting a positive short-term impact.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Tivic Health Systems shares soared 116.8% in pre-market trading with a market cap of $3.7 million.
The substantial pre-market gain for TIVC indicates a positive investor sentiment which could lead to a short-term upward price movement.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Aclaris Therapeutics stock fell sharply by 85.6% to $0.68, with a market value of $48.5 million.
The significant pre-market decline in ACRS stock price indicates a bearish outlook, which could persist in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
TC BioPharm shares plummeted by 89.2% to $0.42 in pre-market trading with a market cap of $3.9 million.
The dramatic pre-market drop for TCBP suggests a negative investor reaction, likely leading to a continued short-term decline in stock price.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Verve Therapeutics stock declined by 31.53% to $10.75, potentially influenced by its Q3 earnings report released 4 days ago.
The drop in VERV's stock price following its Q3 earnings report suggests that the market has reacted unfavorably, indicating a negative short-term impact.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90